Workup and Risk Stratification of Post‑Auricular Masses in Adolescents

History and Physical Examination

A mass that has been present for ≥ 2 weeks or of uncertain duration raises concern for a non‑infectious etiology. [@1]
The absence of a recent upper‑respiratory, ear, or scalp infection makes reactive lymphadenopathy less likely. [@1]
Inquiry about systemic symptoms (fever, night sweats, unexplained weight loss, pharyngitis, otalgia, or skin lesions) is essential for identifying possible malignancy. [@1]
Tobacco and alcohol use are synergistic risk factors for head‑and‑neck cancer, even though they are uncommon in this age group. [@1]
Physical‑exam red flags:
- Size > 1.5 cm – warrants closer evaluation. [@1]
- Firm or hard consistency – more concerning than a soft, fluctuant mass. [@1]
- Fixed or reduced mobility – suggests possible malignancy. [@1]
- Nontender – less likely infectious, more worrisome for neoplasm. [@1]
- Overlying skin ulceration – highly suspicious for malignancy. [@1]
Examine the scalp, face, and post‑auricular skin for primary cutaneous lesions and palpate all cervical lymph‑node chains bilaterally. [@1]
Perform otoscopy to rule out middle‑ear pathology that could mimic or contribute to the mass. [@1]

Tender, mobile, soft mass < 2 weeks in duration, associated with a recent infection or skin lesion, and < 1.5 cm in size. (Praxis Medical Insights) [@4]

Mass > 1.5 cm, firm/hard, fixed, present ≥ 2 weeks without an infectious cause, nontender, or with skin ulceration. (Praxis Medical Insights) [@4]

Contrast‑enhanced CT or MRI of the neck should be obtained for high‑risk masses; both modalities are considered equally effective for oncologic evaluation. [@1]
The American College of Radiology emphasizes the necessity of IV contrast to detect nodal necrosis. [@6]
Routine non‑contrast head CT is discouraged because of low diagnostic yield and unnecessary radiation exposure. [@7]
Referral to otolaryngology should occur within days for patients with high‑risk features. (Praxis Medical Insights) [@4]
Fine‑needle aspiration (FNA) performed by the specialist is recommended when imaging does not provide a definitive diagnosis. [@9]

For low‑risk masses, provide reassurance and education on warning signs, and arrange follow‑up in 2–4 weeks to confirm resolution. [@2]
Avoid empiric antibiotics unless there are clear signs of bacterial infection (e.g., warmth, erythema, fluctuance), as unnecessary antibiotics can delay cancer diagnosis. (Praxis Medical Insights) [@5]
Instruct patients to return promptly if the mass enlarges, becomes fixed, or new systemic symptoms develop. [@2]

Do not prescribe multiple courses of antibiotics without obtaining tissue diagnosis; this is a common cause of delayed cancer detection. (Praxis Medical Insights) [@3]
Do not perform an open excisional biopsy before imaging and specialist evaluation, as it may worsen outcomes and cause tumor spillage. (Praxis Medical Insights) [@5]
Do not assume all masses in young patients are benign; missing a malignancy can have devastating consequences. [@1]

Complete blood count with differential if lymphoma or leukemia is suspected. [@9]
Epstein‑Barr virus serology when infectious mononucleosis is a consideration. [@9]
Bartonella serology if cat‑scratch disease is suspected based on exposure history. [@9]
Routine broad laboratory panels should be avoided because they provide limited diagnostic value in this context. [@9]

All facts are presented in English, with patient‑specific details replaced by generic descriptors.